Matches in SemOpenAlex for { <https://semopenalex.org/work/W1881766039> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1881766039 endingPage "134" @default.
- W1881766039 startingPage "122" @default.
- W1881766039 abstract "Many factors affect an individual's response to a drug, and large inter- ethnic, intra-ethnic, and even intra-individual variations exist. These variations may affect both the therapeutic response to a drug, or the side effects that the patient experiences. Since anti-neoplastic drugs often have a very narrow therapeutic range, it is very desirable to be able to predict these variations in response or to ensure that these variations are as small as possible. It has recently become possible to predict some extreme responses, such as severe side effects, using pharmacogenomic approaches; for example, the uridine diphosphate-glucuronosyltransferase (UGT) 1A1 genetic polymorphism is a predictor of irinotecan toxicity. Further, adding pharmacokinetic and pharmacodynamic information may increase the accuracy of response prediction. Both severe toxicity and clinical benefit can be predicted using a combination of pharmacogenomic and pharmacokinetic information. For example, the clinical benefit obtained from adjuvant treatment with tamoxifen is reduced in patients who have either a particular Cytochrome P450 (CYP) 2D6 genetic polymorphism or who are taking paroxetine, a strong inhibitor of CYP2D6. It is possible to monitor pharmacodynamic parameters, such as serum estrogen levels, as a measure of the therapeutic effect of aromatase inhibitors. In this review, we summarize current knowledge in the field of pharmacogenomics as it relates to breast cancer, focusing particularly on clinical data." @default.
- W1881766039 created "2016-06-24" @default.
- W1881766039 creator A5059944980 @default.
- W1881766039 creator A5067693447 @default.
- W1881766039 creator A5091245889 @default.
- W1881766039 date "2012-03-27" @default.
- W1881766039 modified "2023-09-24" @default.
- W1881766039 title "Pharmacogenomic Considerations in Breast Cancer Management" @default.
- W1881766039 doi "https://doi.org/10.2174/978160805202810904010122" @default.
- W1881766039 hasPublicationYear "2012" @default.
- W1881766039 type Work @default.
- W1881766039 sameAs 1881766039 @default.
- W1881766039 citedByCount "0" @default.
- W1881766039 crossrefType "book-chapter" @default.
- W1881766039 hasAuthorship W1881766039A5059944980 @default.
- W1881766039 hasAuthorship W1881766039A5067693447 @default.
- W1881766039 hasAuthorship W1881766039A5091245889 @default.
- W1881766039 hasConcept C104317684 @default.
- W1881766039 hasConcept C111113717 @default.
- W1881766039 hasConcept C112705442 @default.
- W1881766039 hasConcept C121608353 @default.
- W1881766039 hasConcept C126322002 @default.
- W1881766039 hasConcept C135763542 @default.
- W1881766039 hasConcept C143998085 @default.
- W1881766039 hasConcept C170734499 @default.
- W1881766039 hasConcept C181199279 @default.
- W1881766039 hasConcept C2776166826 @default.
- W1881766039 hasConcept C2777176818 @default.
- W1881766039 hasConcept C2778504769 @default.
- W1881766039 hasConcept C2780035454 @default.
- W1881766039 hasConcept C2780259306 @default.
- W1881766039 hasConcept C2781278898 @default.
- W1881766039 hasConcept C33664856 @default.
- W1881766039 hasConcept C526171541 @default.
- W1881766039 hasConcept C526805850 @default.
- W1881766039 hasConcept C530470458 @default.
- W1881766039 hasConcept C55493867 @default.
- W1881766039 hasConcept C55775858 @default.
- W1881766039 hasConcept C62231903 @default.
- W1881766039 hasConcept C71924100 @default.
- W1881766039 hasConcept C86803240 @default.
- W1881766039 hasConcept C87644729 @default.
- W1881766039 hasConcept C98274493 @default.
- W1881766039 hasConceptScore W1881766039C104317684 @default.
- W1881766039 hasConceptScore W1881766039C111113717 @default.
- W1881766039 hasConceptScore W1881766039C112705442 @default.
- W1881766039 hasConceptScore W1881766039C121608353 @default.
- W1881766039 hasConceptScore W1881766039C126322002 @default.
- W1881766039 hasConceptScore W1881766039C135763542 @default.
- W1881766039 hasConceptScore W1881766039C143998085 @default.
- W1881766039 hasConceptScore W1881766039C170734499 @default.
- W1881766039 hasConceptScore W1881766039C181199279 @default.
- W1881766039 hasConceptScore W1881766039C2776166826 @default.
- W1881766039 hasConceptScore W1881766039C2777176818 @default.
- W1881766039 hasConceptScore W1881766039C2778504769 @default.
- W1881766039 hasConceptScore W1881766039C2780035454 @default.
- W1881766039 hasConceptScore W1881766039C2780259306 @default.
- W1881766039 hasConceptScore W1881766039C2781278898 @default.
- W1881766039 hasConceptScore W1881766039C33664856 @default.
- W1881766039 hasConceptScore W1881766039C526171541 @default.
- W1881766039 hasConceptScore W1881766039C526805850 @default.
- W1881766039 hasConceptScore W1881766039C530470458 @default.
- W1881766039 hasConceptScore W1881766039C55493867 @default.
- W1881766039 hasConceptScore W1881766039C55775858 @default.
- W1881766039 hasConceptScore W1881766039C62231903 @default.
- W1881766039 hasConceptScore W1881766039C71924100 @default.
- W1881766039 hasConceptScore W1881766039C86803240 @default.
- W1881766039 hasConceptScore W1881766039C87644729 @default.
- W1881766039 hasConceptScore W1881766039C98274493 @default.
- W1881766039 hasLocation W18817660391 @default.
- W1881766039 hasOpenAccess W1881766039 @default.
- W1881766039 hasPrimaryLocation W18817660391 @default.
- W1881766039 isParatext "false" @default.
- W1881766039 isRetracted "false" @default.
- W1881766039 magId "1881766039" @default.
- W1881766039 workType "book-chapter" @default.